Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10993998rdf:typepubmed:Citationlld:pubmed
pubmed-article:10993998lifeskim:mentionsumls-concept:C0013384lld:lifeskim
pubmed-article:10993998lifeskim:mentionsumls-concept:C0023570lld:lifeskim
pubmed-article:10993998lifeskim:mentionsumls-concept:C0171023lld:lifeskim
pubmed-article:10993998lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10993998pubmed:issue6lld:pubmed
pubmed-article:10993998pubmed:dateCreated2000-10-4lld:pubmed
pubmed-article:10993998pubmed:abstractTextTo assess the usefulness of low-dose olanzapine (2.5 to 7. 5 mg/day) for Levodopa-induced-dyskinesias (LID) in patients with PD.lld:pubmed
pubmed-article:10993998pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:languageenglld:pubmed
pubmed-article:10993998pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10993998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993998pubmed:statusMEDLINElld:pubmed
pubmed-article:10993998pubmed:monthSeplld:pubmed
pubmed-article:10993998pubmed:issn0028-3878lld:pubmed
pubmed-article:10993998pubmed:authorpubmed-author:LeesA JAJlld:pubmed
pubmed-article:10993998pubmed:authorpubmed-author:SchragAAlld:pubmed
pubmed-article:10993998pubmed:authorpubmed-author:MansonA JAJlld:pubmed
pubmed-article:10993998pubmed:issnTypePrintlld:pubmed
pubmed-article:10993998pubmed:day26lld:pubmed
pubmed-article:10993998pubmed:volume55lld:pubmed
pubmed-article:10993998pubmed:ownerNLMlld:pubmed
pubmed-article:10993998pubmed:authorsCompleteYlld:pubmed
pubmed-article:10993998pubmed:pagination795-9lld:pubmed
pubmed-article:10993998pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:meshHeadingpubmed-meshheading:10993998...lld:pubmed
pubmed-article:10993998pubmed:year2000lld:pubmed
pubmed-article:10993998pubmed:articleTitleLow-dose olanzapine for levodopa induced dyskinesias.lld:pubmed
pubmed-article:10993998pubmed:affiliationNational Hospital for Neurology and Neurosurgery, Queen Square, London, UK.lld:pubmed
pubmed-article:10993998pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10993998pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10993998pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10993998pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10993998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10993998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10993998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10993998lld:pubmed